|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Biophysique Moléculaire & Cellulaire, CNRS UMR5090, CEA/DRDC, 17 rue des Martyrs, 38054 Grenoble, France
2 Department de Biologie Cellulaire & Morphologie (IBCM), Université de Lausanne, 9 rue du Bugnon, 1005 Lausanne, Switzerland
3 Biologie des Neurones Endocrines, CNRS UMR5101, CCIPE, 141 rue de la Cardonille, 34094 Montpellier, France
| Abstract |
|---|
|
|
|---|
(Received 22 March 2004;
accepted after revision 21 June 2004;
first published online 24 June 2004)
Corresponding author M. Vivaudou: Biophysique Moléculaire & Cellulaire, CNRS UMR5090, CEA/DRDC, 17 rue des Martyrs, 38054 Grenoble, France. Email: vivaudou{at}cea.fr
| Introduction |
|---|
|
|
|---|
In pancreatic beta-cells, Zn2+ is necessary to maintain the crystalline structure of insulin in secretory granules (Dodson & Steiner, 1998), and has been proposed to exert a negative feedback upon hormone release by reducing the electrical activity and insulin secretion of beta-cells (Ghafghazi et al. 1981; Ferrer et al. 1984; Aspinwall et al. 1997). These actions of Zn2+ are likely to result from direct interaction with membrane ion channels (Harrison & Gibbons, 1994; Smart et al. 1994; Frederickson & Bush, 2001).
Bloc et al. (2000) proposed that the inhibitory effect of Zn2+ on insulin secretion from pancreatic beta-cells could result at least partly from its potentiating action on ATP-sensitive potassium channels (KATP). These channels are widely distributed among most types of excitable cells, where they couple metabolic status to membrane excitability (Ashcroft & Ashcroft, 1990; Seino & Miki, 2003). In pancreatic beta-cells, KATP channels are involved in glucose-induced insulin secretion whereas in cardiac and neuronal cells, they could have a protective effect against ischaemic damage (Standen, 2002). The KATP channel is a hetero-octameric complex composed of two distinct proteins: the sulphonylurea receptor (SUR), an ATP-binding-cassette (ABC) protein, and an inward rectifier potassium channel, Kir6.x. In pancreatic and cardiac KATP channels, four Kir6.2 assemble to form a K+-selective pore, which is constitutively associated with four SUR subunits (Seino & Miki, 2003). SUR serves as a sensor of metabolic adenine nucleotide changes and is the target of pharmacological modulators of the channel: blockers, like the sulphonylureas, and potassium channel openers such as cromakalim and pinacidil. Pancreatic and neuronal KATP channels contain the SUR1 isoform, whereas the channel in cardiac and skeletal muscle cells is formed with the SUR2A isoform (Terzic & Vivaudou, 2001).
Apart from its extracellular action, Zn2+ can also enter cells via various routes and act as an intracellular messenger (Li et al. 2001; Frederickson & Bush, 2001). Zn2+ can permeate membranes either directly through ligand-gated channels such as glutamate or nicotinic receptors (Sensi et al. 1997; Ragozzino et al. 2000; Jia et al. 2002), voltage-activated Ca2+ channels (Kerchner et al. 2000; Sheline et al. 2002) and other channels (Monteilh-Zoller et al. 2003), or through transporters (Weiss et al. 2000; Gaither & Eide, 2001). Entry of Zn2+ may alter protein structure and function, as well as gene expression (Weiss et al. 2000; Frederickson & Bush, 2001), but may also modulate channels from the intracellular compartment (Tabata & Ishida, 1999; Wang et al. 2001).
We here report the potentiation of KATP channels by intracellular Zn2+, and compare it with that induced by extracellular application of Zn2+ (Bloc et al. 2000). We further investigate these effects of Zn2+ as a function of the subunit composition of the channel and show that, on either side of the membrane, SUR is the most probable target of Zn2+.
| Methods |
|---|
|
|
|---|
Clones. Rat Kir6.2 (GenBank accession X97041) and rat SUR1 (GenBank accession X97279) cDNAs were cloned from the rat insulinoma cell line RINm5F, using a RT-PCR-based strategy. Rat SUR2A cDNAs (GenBank accession D83598) and mouse Kir6.2 (GenBank accession D50581) were kindly provided by Dr S. Seino. Hamster SUR1 (GenBank accession L40623) was kindly provided by Dr J. Bryan.
Cell lines. For expression in COS-7 cells, rat Kir6.2, SUR1, and SUR2A cDNAs were subcloned into the expression vector pcDNA3 (Invitrogen). Transfections were performed overnight by CaCl2 precipitation with 4 µg per well of Kir6.2 + SURx combinations (ratio 1:3), together with 0.5 µg of vector pE-GFP (Invitrogen). Twenty-four hours after transfection, cells were plated and cultured in Dulbecco's modified Eagle's medium (DMEM) for 13 days before recordings. Cells expressing GFP were identified by fluorescence microscopy and used for electrophysiology.
Xenopus oocyte expression.
Mouse Kir6.2, hamster SUR1 and rat SUR2A were subcloned in Xenopus oocyte expression vectors derived from the vector pGEMHE (Liman et al. 1992). Mutations were introduced in these plasmids by PCR (QuickChange Site-Directed Mutagenesis Kit, Stratagene). For the Kir6.2
C36 construct, a premature stop codon was introduced at the correct position. After amplification and linearization, plasmid DNAs were transcribed in vitro by using the T7 mMessage mMachine Kit (Ambion) to produce cRNA for subsequent oocyte microinjection.
Female Xenopus laevis were anaesthetized with 3-aminobenzoic acid ethyl ester (1 g l1 of water). Part of one ovary was removed with a minilaparotomy, the incision was sutured, and the animal was allowed to recover. Animal handling and experiments fully conformed with French regulations and were approved by local governmental veterinary services (authorization No. 28-03-15 delivered by the Ministère de l'Agriculture, Direction des Services Vétérinaires to M.V). Frogs were humanely killed by decapitation after final collection of oocytes from both ovaries.
Stage V or VI oocytes were defolliculated by a 60-min incubation at 19°C with 2 mg ml1 type A collagenase (Sigma). Selected oocytes were injected the next day with cRNAs encoding wild-type or truncated Kir6.2 (2 ng) and wild-type or modified SURs (6 ng). Injected oocytes were stored at 19°C in Barth's solution (in mM: 1 KCl, 0.82 MgSO4, 88 NaCl, 2.4 NaHCO3, 0.41 CaCl2, 0.3 Ca(NO3)2, 16 Hepes, pH 7.4) supplemented with 100 U ml1 penicillin, 100 µg ml1 streptomycin and 100 µg ml1 gentamycin. Three to five days after injection, oocytes were devitellinized and recombinant KATP channels were characterized by the patch-clamp technique in the excised inside-out or outside-out configuration.
Electrophysiology
All experiments were carried out at room temperature (2022°C). ATP-containing solutions were prepared immediately before the experiments. Diazoxide, tolbutamide and glibenclamide (Sigma) were diluted to their final concentrations from stock solutions in DMSO at 100, 100, and 20 mM, respectively. At the concentrations used, DMSO had no effect on channel activity (D'hahan et al. 1999a). The indicated concentrations of Zn2+ (chloride salt; Fluka) represent free zinc as calculated by the program ALEX (Vivaudou et al. 1991). In our experimental conditions, ATP was the only Zn2+ complexant. Since Zn2+ binds to ATP with a dissociation constant
15 µM, we used Zn2+ concentrations low enough to limit effects due solely to interactions with ATP. Thus in our experimental conditions, the fraction of ATP complexed with Zn2+ was at most 11% (a value reached when 31 µM Zn was mixed with 100 µM ATP to yield 20 µM free Zn2+ and 11 µM ZnATP2).
Cell lines.
For whole-cell recording, the external bath solution contained (mM): 145 NaCl, 3 KCl, 2 CaCl2, 2 MgCl2, 10 Hepes, 10 D-glucose, pH 7.2, and patch pipettes (23 M
) contained (in mM): 10 NaCl, 140 KCl, 1 MgCl2, 10 Hepes, 1 EGTA, 1 Mg-ATP, pH 7.2. In the inside-out configuration, bath and pipette (510 M
) solutions were identical with (in mM): 10 NaCl, 140 KCl, 2 MgCl2, 10 Hepes, pH 7.2. Applications of the various solutions were performed using a gravity solution-changer controlled by electrovalves. Capacitive transients and series resistance were compensated. Signals were analysed with pClamp8 software (Axon Instruments).
Xenopus oocytes.
For inside-out recordings, patch pipettes (210 M
) contained (mM): 136 KCl, 5 MgCl2, 10 PIPES, 18 KOH, pH 7.1. DTPA (diethyle-netriaminepentaacetic acid; Sigma) and EGTA were added when specified. Patches were bathed in solutions that contained (in mM): 38 KCl, 92 KCH3SO3, 1 MgCl2, 10 PIPES, 20 KOH, pH 7.1. Except where noted, EGTA was used at 1 mM. ATP (potassium salt; Sigma) was added as specified. For outside-out recordings, above pipette and bath solutions were switched to yield the same intra- and extracellular solutions. Unless otherwise specified, experiments were conducted at the Cl reversal potential (
30 mV) determined for each patch as the potential at which no current was induced by the removal of the Ca2+ chelator EGTA. Applications of the various solutions to the patch were performed using an RSC-100 rapid-solution-changer (Bio-Logic). Acquisition and analysis were performed with in-house software. Slow fluctuations of the baseline were removed by interactive fitting with a spline curve and subtraction of this fit from the signal. Single channel analysis (all-point histograms and fits) were performed with Origin software (OriginLab). Open probability was calculated as the overall time spent in open states over total recording time. Model fitting to the currents measured in 100 µM ATP normalized to the current measured in 0 ATP was done with Origin using a standard Hill equation:
|
| (1) |
the concentration for half-maximal inhibition and n the Hill coefficient. Results are displayed as the mean ±S.E.M.
| Results |
|---|
|
|
|---|
Previous experiments showed that extracellular Zn2+ activates KATP channels in the pancreatic cell line RIN5mF (Bloc et al. 2000). In order to better understand the effects of Zn2+ on KATP channels, experiments were conducted on recombinant KATP channels formed with the pancreatic combination of subunits SUR1 and Kir6.2. Whole-cell voltage-clamp recordings were performed on COS-7 cells transfected with SUR1/Kir6.2 (Fig. 1). Large currents elicited by slow voltage ramps were suppressed in the presence of the SUR1-selective KATP blocker tolbutamide (300 µM) and reversed close to the K+ equilibrium potential. These currents were potentiated by bath application of Zn2+ (20 µM). Potentiation was absent in the presence of tolbutamide, confirming that Zn2+ activated KATP currents. On average, 20 µM Zn2+ potentiated the current measured at 40 mV by 42 ± 9% (Fig. 1C), a value similar to that reported for native channels of RIN5mF cells (Bloc et al. 2000). Similarly, outside-out patches excised from Xenopus oocytes expressing SUR1/Kir6.2 showed channel activity that was enhanced both by the SUR1 opener diazoxide (100 µM) and by bath application of Zn2+ (20 µM), and was inhibited by tolbutamide (200 µM; Fig. 2A). The increase in open probability (Po) was variable from patch to patch, depending on the initial level of activity of the channels. On average, Po increased from 0.22 ± 0.06 to 0.42 ± 0.07 (131 ± 40% increase; n= 6).
|
|
In order to assess which subunit was responsible for the potentiating effect of Zn2+, we also tested Zn2+ on cells expressing the cardiac isoform of the channel composed of the SUR2A and Kir6.2 subunits. The cardiac SUR2A/Kir6.2 channel is characterized by a lower sensitivity to sulphonylureas than the pancreatic form of the channel (SUR1/Kir6.2), and is activated by openers such as cromakalim and pinacidil, but not by diazoxide (in absence of internal ADP; D'hahan et al. 1999b).
In contrast to its action on SUR1/Kir6.2 channel, application of 20 µM extracellular Zn2+ did not potentiate the SUR2A/Kir6.2 channel expressed either in COS-7 cells (n= 12; Fig. 1) or in Xenopus oocytes (n= 4 outside-out patches, data not shown). Rather, Zn2+ induced a small reversible inhibition of the KATP current (Fig. 1). This indicates that the SUR subunit is critical to extracellular Zn2+ action, with a specificity towards SUR1-containing channels.
Modulation of recombinant KATP channels by intracellular Zn2+
Unexpectedly, Zn2+ applied to the intracellular face of the channel also had profound effects on channel activity. Characterization of this effect was performed on Xenopus oocytes coinjected with SUR and Kir6.2, from which KATP currents of hundreds of pA can be recorded in a single patch (D'hahan et al. 1999a). In Xenopus oocytes, inside-out patch recordings are routinely performed in the presence of the Ca2+ chelator EGTA in the bath to prevent activation by residual Ca2+ of endogenous Ca2+-activated Cl currents (ICl(Ca)). Because EGTA also chelates Zn2+, application of Zn2+ requires removal of EGTA from the bath solution, and experiments were therefore conducted at the Cl equilibrium potential (ECl) to prevent contamination by ICl(Ca). ECl was precisely measured in each patch as the membrane potential at which no current was induced by removal of EGTA. These precautions were necessary because Zn2+ was found to block the endogenous ICl(Ca) conductance, identified as such because it reversed at ECl and was activated by removal of EGTA. Intracellular Zn2+ (2 and 20 µM) had an inhibitory effect on Cl current, reducing both the outward current at 0 mV and the inward currents at 50 mV (Fig. 3). At ECl, the potential used to record KATP channels, Zn2+ had no effect in uninjected oocytes.
|
80% channel inhibition, bath application of 20 µM Zn2+ activated both SUR1/Kir6.2 and SUR2A/Kir6.2 KATP channels (Fig. 4A and B). Potentiation by Zn2+ was dose dependent (Fig. 4C), with a clearly greater affinity for SUR1/Kir6.2 than SUR2A/Kir6.2 channels (Fig. 4D). Since Zn2+ concentrations above 20 µM could not be used for fear of indirect effects due to ATP chelation (see Methods), the degree of maximal activation could not be ascertained. Assuming channel activity could be raised by Zn2+ to the level obtained in the absence of ATP, Hill equation fitting yielded K
of 1.8 and 60 µM for SUR1 and SUR2A, respectively (Fig. 4D). These values became 1.3 and 5.1 µM if the levels obtained in 20 µM Zn2+ were taken as maximal.
|
C36, from which the last 36 amino acids were deleted (Tucker et al. 1997), removing the endoplasmic reticulum retention signal present on the C-terminal extremity (Zerangue et al. 1999). This allows the expression at the plasma membrane of functional channels formed solely by the Kir6.2 subunit, albeit at a lower density than wild-type KATP channels. Application of internal Zn2+ (20 µM) on inside-out patches from oocytes expressing Kir6.2
C36 channels, either in the absence (data not shown) or in the presence of ATP (100 µM), caused a slight reduction in current which was not statistically significant (P > 0.2; Student's paired t test). These results point to the SUR protein as the target of both extra- and intracellular Zn2+. The bilateral effects of Zn2+ do not entail crossmembrane transit
Although it would be unlikely in our recording configurations, the possibility exists that Zn2+ could somehow cross the membrane to reach its site of action, thus explaining how internal and external Zn2+ can have similar effects. In order to test for such a mechanism, experiments were reproduced in the presence of the Zn2+ chelators EGTA (100 µM; n= 3) or DTPA (100 µM; n= 5) in the patch pipette. Neither chelator on the intracellular face prevented the extracellular effect of Zn2+, which still increased SUR1/Kir6.2 currents to a similar extent (Fig. 5A). Similarly, the presence of the chelators DTPA (100 µM; n= 3) or EGTA (100 µM; n= 9) on the extracellular side of the membrane did not prevent the increase in KATP currents induced by application of Zn2+ on the intracellular side of the membrane (Fig. 5B).
|
|
| Discussion |
|---|
|
|
|---|
Inhibition of Xenopus oocyte Ca2+-activated Cl currents by Zn2+
During the course of this work, we discovered that intracellular Zn2+ inhibited the most prominent endogenous currents of Xenopus oocytes, Ca2+-activated Cl currents (ICl(Ca)). Previous studies have reported that micromolar concentrations of extracellular divalent cations, including Zn2+, induced ICl(Ca) in Xenopus oocytes, but that internal injections of Zn2+ had no effect (Miledi et al. 1989). However, when applied onto excised patches, intracellular Zn2+ (220 µM) inhibited a current identified as ICl(Ca) by its activation upon EGTA removal and its reversal at the predicted Cl equilibrium potential. Although we did not further characterize this effect, which represented the only effect of Zn2+ on endogenous conductances under our experimental conditions, we did consider it carefully when recording effects of Zn2+ on KATP channels heterologously expressed in Xenopus oocytes. Ionic concentrations were adjusted to have ECl (
30 mV) and EK (
0 mV) sufficiently distant so that sizable K+ currents could be measured at ECl. Furthermore, the actual ECl was determined in each patch to within 1 mV, as the reversal potential of ICl(Ca). In this manner, effects of intracellular Zn2+ on endogenous Cl and exogenous K+ conductances could be characterized separately with minimal interference.
Pancreatic KATP channels are activated by extra- and intracellular Zn2+
Bloc et al. (2000) reported that micromolar concentrations of Zn2+ increased the open-state probability of endogenous KATP channels in the pancreatic RIN5mF cell line. We substantiated this observation by showing that extracellular Zn2+ also activated recombinant SUR1/Kir6.2 channels heterologously expressed in either COS-7 cells or Xenopus oocytes. Potentiation was rapid, reaching its maximum within a few seconds, and reversed with similarly fast kinetics.
Unexpectedly, application of Zn2+ to the intracellular side of the membrane also led to activation of KATP channels. Intracellular Zn2+ at submicromolar concentrations has been shown to inhibit Cl channels in neurones (Tabata & Ishida, 1999), but to our knowledge, this is the first observation of the agonist effect of an internal transition metal on identified potassium channels, (Miledi et al. (1989) did report activation by high external Zn2+ of a K+ conductance in Xenopus oocyte follicular cells), and the first reported case of a channel activated by a non-permeant ligand from both sides of the membrane. For SUR1/Kir6.2 channels expressed in oocytes, measurements over a number of experiments gave a half-maximal concentration of 1.8 µM but there were significant differences in the responses of individual patches. This value is remarkably close to the value of 1.7 µM measured under different experimental conditions as being the concentration for half-maximal activation by extracellular Zn2+ (Bloc et al. 2000). The amplitude of the effect was comparable to that of pharmaceutical potassium channel openers since, in most patches, 20 µM Zn2+ was sufficient to fully reverse the inhibition caused by the 100 µM ATP present during our tests.
Isoform-dependent modulation of KATP channels by extracellular and intracellular Zn2+
The potentiation of KATP channels by extracellular Zn2+ appeared specific to the pancreatic channel, since Zn2+ failed to activate the cardiac form of KATP channels (SUR2A/Kir6.2), and even elicited a weak inhibition of these channels at the highest concentration tested of 20 µM.Kwok & Kass (1993) showed that such a concentration also inhibited native channels but to a much greater extent. Since they recorded Zn2+ effects on pinacidil-activated currents, the discrepancy could arise from a possible antagonism between K+ channel openers and Zn2+, not unlike that between openers and protons (Forestier et al. 1996).
Kwok & Kass (1993) also tested internal Zn2+ on ventricular myocyte channels and, even though they concluded a lack of inhibition, an activation, evident in their Fig. 4, could have been overlooked. In our hands, intracellular Zn2+ activated both the pancreatic and cardiac forms of KATP channels with a strong preference for the former. This dose-dependent effect, when modelled with sigmoidal functions, yielded K
in the range of 12 µM for SUR1/Kir6.2 and 560 µM for SUR2A/Kir6.2 channels. In both cases, the Hill coefficient was close to 1, indicative of a simple bimolecular reaction. This SUR-dependent difference, together with the lack of effects of Zn2+ on truncated Kir6.2 channels expressed alone, designates the sulphonylurea receptor as the primary target of intracellular Zn2+.
Possible mechanisms for Zn2+ potentiation of KATP currents
The first hypothesis that one could put forward about the effects of Zn2+ is that of an unspecific action related to the ionic nature of the effector. However, no such effects have been described for the other physiological divalent cations, Mg2+ and Ca2+. Furthermore, Zn2+ effects were recorded in the presence of Mg2+, present on both sides of the membrane throughout our experiments in large excess (>1 mM), and Ca2+, present outside in millimolar concentrations and inside in micromolar concentrations (as evidenced by the potent activation of ICl(Ca) upon removal of the chelator EGTA). A mechanism involving alterations of membrane surface charge (Vivaudou & Forestier, 1995) is therefore implausible. Likewise, interaction of intracellular Zn2+ with nucleotides could not lead to significant activation: first, Zn2+ will reduce free ATP by chelating it, possibly affecting the inhibitory potency of ATP on the Kir6.2 subunit, but our experimental conditions were designed to minimize this effect by keeping zinc-bound ATP at less than 11% of total ATP. Second, low concentrations of MgATP have been shown to activate KATP channels through the SUR subunit (Gribble et al. 1998), but a similar effect of ZnATP would not be consistent with the available evidence demonstrating that Zn2+ cannot mimic Mg2+ in supporting nucleotide binding to ABC transporters (Cai et al. 2002).
This line of reasoning pleads for a more sophisticated mechanism involving Zn2+-specific receptor sites. The finding for SUR1 that the same molecule has the same, singular effects on an integral membrane protein when applied from either side of the membrane, intuitively suggests a single site of action. However, when we applied Zn2+ on one side, with a chelator on the other side, neither intra- nor extracellular effects were disturbed even though the concentration dependence of channel activation showed that Zn2+ has a 104-higher affinity for the chelator, EGTA or DTPA, than for its receptor. This experiment suggests that the intracellular Zn2+ site is not seen from outside and vice versa. This evidence favours the existence of two distinct sites mediating the same effect. These sites would be located near or on the SUR protein itself since, first, the effects were dependent on the SUR isoform and were not seen with SUR-less channels, and second, the rapid onset and reversal of Zn2+ activation appears incompatible with long-range signalling mechanisms, such as a receptor-regulated metabolic process involving the zinc-sensing receptor ZnR (Hershfinkel et al. 2001). This G-protein-coupled receptor linked to phospholipase C is probably present in Xenopus oocytes as this would nicely explain the effects of external Zn2+ recorded by Miledi et al. (1989). Activation of phospholipase C by ZnR would result in a decrease in phosphatidylinositol 4,5-bisphosphate which would increase ATP sensitivity of the KATP channels and cause an inhibition of the channel (Xie et al. 1999; Kakei, 2003). Such a mechanism could sustain the delayed inhibition subsequent to application of external Zn2+ observed by Bloc et al. (2000), but cannot account for a potentiating effect of Zn2+. Cytosolic Zn2+ interacts nonetheless with a number of enzymes (Beyersmann & Haase, 2001) one of which is protein kinase C (PKC), which has been linked to KATP channel activation (Light, 1996). With a Zn2+-dependent PKC having been reported to downregulate a Cl conductance (Tabata & Ishida, 1999), a PKC role in intracellular Zn2+ activation of KATP channels cannot be ruled out but remains highly speculative because PKC activation of KATP channels depends on the Kir6.2 subunit (Light et al. 2000), but Zn2+ activation does not.
Considering a more direct pathway, the hypothesis of metal binding sites on SUR seems plausible because other IIb transition metals, such as Cd2+, can be transported by Ycf1p and Mrp1, ABC proteins that present a high degree of homology with SUR (Li et al. 1997; Tommasini et al. 1996), and because some prok aryotic ABC proteins are known to transport Zn2+ (Hantke, 2001). Zn2+ could even act as a substrate of SUR, not unlike the hypothesis raised for K+ channel openers (Moreau et al. 2000). However, SUR having mutations known to disable nucleotide-dependent transport activity of ABC transporters, retained sensitivity to Zn2+. This experiment argues against the necessity of a transport of Zn2+ for activating the channel, but it leaves open for further studies the possibility that a unique site of action of Zn2+ could lie within a transport pathway where chelators would not have access.
Physiological significance
In neurones, Zn2+ is concentrated in synaptic vesicles and cosecreted with neurotransmitters upon stimulation, and it is believed to act as a neuromodulator at excitatory synapses (Huang, 1997). In pancreatic beta-cells, Zn2+ accmulates in secretory granules, where it forms hexamers with insulin. These microcrystals dissolve during exocytosis and large amounts of Zn2+ are coreleased with insulin. It has been proposed that by activating KATP channels and hyperpolarizing cells, Zn2+ could exert a negative feedback on insulin secretion (Bloc et al. 2000). Aspinwall et al. (1999) have shown that released insulin stimulates insulin secretion via a positive feedback mechanism, and they suggested that some mechanism should take over to counteract this feedback. Stimulating KATP channels by Zn2+ coreleased with insulin could constitute one such mechanism. Zn2+ was also postulated to be responsible for the cross-talk between beta-cells and alpha-cells in pancreatic islets, whereas insulin secretion by beta-cells induces suppression of glucagon release by alpha-cells (Ishihara et al. 2003).
If extracellular Zn2+ can reach the micromolar levels used in this study (Weiss et al. 2000), intracellular free Zn2+ concentration is tightly controlled and maintained in the low nanomolar range (Sensi et al. 1997; Beyersmann & Haase, 2001). Since we have measured half-maximal activation of pancreatic/neuronal and muscle KATP channels at 1.8 and 60 µM, respectively, one could confidently conclude that cytosolic Zn2+ activation is a laboratory artefact that will never be seen under physiological conditions. The same could be said of ATP which inhibits KATP channels with micromolar affinities, but never goes below millimolar concentrations in living cells. Cook et al. (1988) settled that controversy by demonstrating that KATP channels can efficiently modulate membrane potential by operating at the very bottom of the doseresponse curve for ATP, where inhibition is 99% or more. This argument applies to cytosolic Zn2+ activation as well: using the model curves fit to the data, it is predicted that 1% activation above control of SUR1/Kir6.2 and SUR2A/Kir6.2 can be achieved with 0.5 nM and 4 nM Zn2+, respectively. These concentrations are well within the limits of the feasible, without even postulating the existence of Zn2+-enriched microdomains which might well play a role due to tight coupling between KATP channels and Zn2+-permeant Ca2+ channels (Shibasaki et al. 2003).
What could then be the physiological role of intracellular Zn2+ potentiation of KATP channels? One possible role would be to protect cells against the cytotoxic effects of elevated internal Zn2+ (Kim et al. 2000; Frederickson & Bush, 2001). Depolarizing stimuli can drive Zn2+ entry through voltage-dependent Ca2+ channels in the presence of physiological amounts of other cations, including Ca2+ in cardiac myocytes (Atar et al. 1995) or in neurones (Sensi et al. 1997; Kerchner et al. 2000). Maintaining cells hyperpolarized by opening KATP channels could thus prevent further entry of Zn2+ through Ca2+ channels, by keeping them from being activated. Such a scheme could reinforce the negative feedback effect of external Zn2+ on insulin secretion discussed above (Bloc et al. 2000). In cardiac myocytes, Zn2+ could act as an endogenous opener of KATP channels, reducing the force of contraction of the myocardium, and thus preventing ischaemiareperfusion injury as do classical potassium channel openers (Terzic & Vivaudou, 2001).
In pancreatic beta-cells or neurones, an increase in cytosolic Zn2+ could potentially occur during perturbation of the Zn2+-accmulating machinery of secretory granules. This could happen during metabolic distress or after sustained secretion leading to penury of secretory granules and reduction in the cytosolic Zn2+-storage capacity of cells. In both cases, opening of KATP channels would provide a resting period for the cell by decreasing its excitability, thus reducing metabolic demand, and at the same time would decrease ambient Zn2+ by reducing secretion.
| References |
|---|
|
|
|---|
Aspinwall CA, Brooks SA, Kennedy RT & Lakey JR (1997). Effects of intravesicular H+ and extracellular H+ and Zn2+ on insulin secretion in pancreatic beta cells. J Biol Chem 272, 3130831314.
Aspinwall CA, Lakey JR & Kennedy RT (1999). Insulin stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 274, 63606365.
Atar D, Backx PH, Appel MM, Gao WD & Marban E (1995). Excitationtranscription coupling mediated by zinc influx through voltage-dependent calcium channels. J Biol Chem 270, 24732477.
Beyersmann D & Haase H (2001). Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 14, 331341.[CrossRef][Medline]
Bloc A, Cens T, Cruz H & Dunant Y (2000). Zinc-induced changes in ionic currents of clonal rat pancreatic beta-cells: activation of ATP-sensitive K+ channels. J Physiol 529, 723734.
Cai J, Daoud R, Alqawi O, Georges E, Pelletier J & Gros P (2002). Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6). Biochemistry 41, 80588067.[CrossRef][Medline]
Cook DL, Satin LS, Ashford MLJ & Hales CN (1988). ATP-sensitive K+ channels in pancreatic ß-cells Spare channel hypothesis. Diabetes 37, 495498.[Abstract]
D'hahan N, Jacquet H, Moreau C, Catty P & Vivaudou M (1999a). A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K+ channels by K+ channel openers. Mol Pharmacol 56, 308315.
D'hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A et al. (1999b). Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A 96, 1216212167.
Dodson G & Steiner D (1998). The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol 8, 189194.[CrossRef][Medline]
Ferrer R, Soria B, Dawson CM, Atwater I & Rojas E (1984). Effects of Zn2+ on glucose-induced electrical activity and insulin release from mouse pancreatic islets. Am J Physiol 246, C520527.[Medline]
Forestier C, Pierrard J & Vivaudou M (1996). Mechanism of action of K channel openers on skeletal muscle KATP channels Interactions with nucleotides and protons. J Gen Physiol 107, 489502.
Frederickson CJ & Bush AI (2001). Synaptically released zinc: physiological functions and pathological effects. Biometals 14, 353366.[CrossRef][Medline]
Gaither LA & Eide DJ (2001). Eukaryotic zinc transporters and their regulation. Biometals 14, 251270.[CrossRef][Medline]
Ghafghazi T, McDaniel ML & Lacy PE (1981). Zinc-induced inhibition of insulin secretion from isolated rat islets of Langerhans. Diabetes 30, 341345.[Abstract]
Gribble FM, Tucker SJ, Haug T & Ashcroft FM (1998). MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A 95, 71857190.
Hantke K (2001). Bacterial zinc transporters and regulators. Biometals 14, 239249.[CrossRef][Medline]
Harrison NL & Gibbons SJ (1994). Zn2+: an endogenous modulator of ligand- and voltage-gated ion channels. Neuropharmacology 33, 935952.[CrossRef][Medline]
Hershfinkel M, Moran A, Grossman N & Sekler I (2001). A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci U S A 98, 1174911754.
Huang EP (1997). Metal ions and synaptic transmission: think zinc. Proc Natl Acad Sci U S A 94, 1338613387.
Ishihara H, Maechler P, Gjinovci A, Herrera PL & Wollheim CB (2003). Islet beta-cell secretion determines glucagon release from neighbouring a-cells. Nat Cell Biol 5, 330335.[CrossRef][Medline]
Jia YS, Jeng JM, Sensi SL & Weiss JH (2002). Zn2+ currents are mediated by calcium-permeable AMPA/kainate channels in cultured murine hippocampal neurones. J Physiol 543, 3548.
Kakei M (2003). Receptor-operated regulation of ATP-sensitive K+ channels via membrane phospholipid metabolism. Curr Med Chem 10, 235243.[Medline]
Kerchner GA, Canzoniero LM, Yu SP, Ling C & Choi DW (2000). Zn2+ current is mediated by voltage-gated Ca2+ channels and enhanced by extracellular acidity in mouse cortical neurones. J Physiol 528, 3952.
Kim BJ, Kim YH, Kim S, Kim JW, Koh JY, Oh SH et al. (2000). Zinc as a paracrine effector in pancreatic islet cell death. Diabetes 49, 367372.[Abstract]
Kwok WM & Kass RS (1993). Block of cardiac ATP-sensitive K+ channels by external divalent cations is modulated by intracellular ATP evidence for allosteric regulation of the channel protein. J Gen Physiol 102, 693712.
Li Y, Hough CJ, Suh SW, Sarvey JM & Frederickson CJ (2001). Rapid translocation of Zn2+ from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation. J Neurophysiol 86, 25972604.
Li ZS, Lu YP, Zhen RG, Szczypka M, Thiele DJ & Rea PA (1997). A new pathway for vacuolar cadmium sequestration in Saccharomyces cerevisiae: YCF1-catalyzed transport of bis (glutathionato) cadmium. Proc Natl Acad Sci U S A 94, 4247.
Light P (1996). Regulation of ATP-sensitive potassium channels by phosphorylation. BBA-Rev Biomembranes 1286, 6573.
Light PE, Bladen C, Winkfein RJ, Walsh MP & French RJ (2000). Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci USA 97, 90589063.
Liman ER, Tytgat J & Hess P (1992). Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron 9, 861871.[CrossRef][Medline]
Lin DD, Cohen AS & Coulter DA (2001). Zinc-induced augmentation of excitatory synaptic currents and glutamate receptor responses in hippocampal CA3 neurons. J Neurophysiol 85, 11851196.
Maret W (2001). Crosstalk of the group IIa and IIb metals calcium and zinc in cellular signaling. Proc Natl Acad Sci U S A 98, 1232512327.
Miledi R, Parker I & Woodward RM (1989). Membrane currents elicited by divalent cations in Xenopus oocytes. J Physiol 417, 173195.
Monteilh-Zoller MK, Hermosura MC, Nadler MJS, Scharenberg AM, Penner R & Fleig A (2003). TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 121, 4960.[CrossRef][Medline]
Moreau C, Jacquet H, Prost AL, D'Hahan N & Vivaudou M (2000). The molecular basis of the specificity of action of K-ATP channel openers. EMBO J 19, 66446651.[CrossRef][Medline]
Ragozzino D, Giovannelli A, Degasperi V, Eusebi F & Grassi F (2000). Zinc permeates mouse muscle ACh receptor channels expressed in BOSC 23 cells and affects channel function. J Physiol 529, 8391.
Seino S & Miki T (2003). Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 81, 133176.[CrossRef][Medline]
Sensi SL, Canzoniero LMYuSP, Ying HS, Koh JY, Kerchner GA et al. (1997). Measurement of intracellular free zinc in living cortical neurons: routes of entry. J Neurosci 17, 95549564.
Sheline CT, Ying HS, Ling CS, Canzoniero LM & Choi DW (2002). Depolarization-induced 65zinc influx into cultured cortical neurons. Neurobiol Dis 10, 4153.[CrossRef][Medline]
Shibasaki T, Sunaga Y, Fujimoto K, Kashima Y & Seino S (2003). Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent calcium channel in insulin granule exocytosis. J Biol Chem 279, 79567961.[CrossRef][Medline]
Smart TG, Xie X & Krishek BJ (1994). Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog Neurobiol 42, 393341.[CrossRef][Medline]
Standen NB (2002). Cardioprotection by preconditioning: K-ATP channels, metabolism, or both?J Physiol 542, 666.
Tabata T & Ishida AT (1999). A zinc-dependent Cl current in neuronal somata. J Neurosci 19, 51955204.
Terzic A & Vivaudou M (2001). Molecular pharmacology of ATP-sensitive K+ channels: how and why?In Potassium Channels in Cardiovascular Biology, ed. Archer SL, Rusch NJ, pp. 257277. Kluwer Academic/Plenum Publishers, New York.
Tommasini R, Evers R, Vogt E, Mornet C, Zaman GJ, Schinkel AH et al. (1996). The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1. Proc Natl Acad Sci U S A 93, 67436748.
Tucker SJ, Gribble FM, Zhao C, Trapp S & Ashcroft FM (1997). Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature 387, 179183.[CrossRef][Medline]
Vallee BL & Falchuk KH (1993). The biochemical basis of zinc physiology. Physiol Rev 73, 79118.
Vivaudou MB, Arnoult C & Villaz M (1991). Skeletal muscle ATP-sensitive potassium channels recorded from sarcolemmal blebs of split fibers: ATP inhibition is reduced by magnesium and ADP. J Membr Biol 122, 165175.[CrossRef][Medline]
Vivaudou M & Forestier C (1995). Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition. J Physiol 486, 629645.[Medline]
Wang H, Wei QQ, Cheng XY, Chen KY & Zhu PH (2001). Inhibition of ryanodine binding to sarcoplasmic reticulum vesicles of cardiac muscle by Zn2+ ions. Cell Physiol Biochem 11, 8392.[CrossRef][Medline]
Weiss JH, Sensi SL & Koh JY (2000). Zn2+: a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 21, 395401.[CrossRef][Medline]
Xie LH, Horie M & Takano M (1999). Phospholipase C-linked receptors regulate the ATP-sensitive potassium channel by means of phosphatidylinositol 4,5-bisphosphate metabolism. Proc Natl Acad Sci U S A 96, 1529215297.
Zerangue N, Schwappach B, Jan YN & Jan LY (1999). A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K-ATP channels. Neuron 22, 537548.[CrossRef][Medline]
| Acknowledgements |
|---|
This article has been cited by other articles:
![]() |
H. Zhou, T. Zhang, J. S. Harmon, J. Bryan, and R. P. Robertson Zinc, Not Insulin, Regulates the Rat {alpha}-Cell Response to Hypoglycemia In Vivo Diabetes, April 1, 2007; 56(4): 1107 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Traboulsie, J. Chemin, M. Chevalier, J.-F. Quignard, J. Nargeot, and P. Lory Subunit-specific modulation of T-type calcium channels by zinc J. Physiol., January 1, 2007; 578(1): 159 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xie and P.-H. Zhu Biphasic Modulation of Ryanodine Receptors by Sulfhydryl Oxidation in Rat Ventricular Myocytes Biophys. J., October 15, 2006; 91(8): 2882 - 2891. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munoz, M. Hu, K. Hussain, J. Bryan, L. Aguilar-Bryan, and A. S. Rajan Regulation of Glucagon Secretion at Low Glucose Concentrations: Evidence for Adenosine Triphosphate-Sensitive Potassium Channel Involvement Endocrinology, December 1, 2005; 146(12): 5514 - 5521. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hussain, J. Bryan, H. T. Christesen, K. Brusgaard, and L. Aguilar-Bryan Serum Glucagon Counterregulatory Hormonal Response to Hypoglycemia Is Blunted in Congenital Hyperinsulinism Diabetes, October 1, 2005; 54(10): 2946 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kim, J.-Y. Park, H.-W. Kang, E.-J. Lee, H. Bang, and J.-H. Lee Zinc Activates TREK-2 Potassium Channel Activity J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 618 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim {beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release Diabetes, June 1, 2005; 54(6): 1808 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bancila, T. Cens, D. Monnier, F. Chanson, C. Faure, Y. Dunant, and A. Bloc Two SUR1-specific Histidine Residues Mandatory for Zinc-induced Activation of the Rat KATP Channel J. Biol. Chem., March 11, 2005; 280(10): 8793 - 8799. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||